National Institutes of Health OLAO
FederalMD
Aug 11, 2026
Closes
Aug 23, 2026
Notice of Intent to Sole Source – Roche Diagnostics BenchMark ULTRA Reagents & Consumables
The National Institutes of Health intends to obtain Roche Ventana BenchMark ULTRA reagents, consumables, and associated service support for immunohistochemistry and in-situ hybridization testing at the Clinical Center in Bethesda, Maryland. The planned contract covers one year, from September 1, 2026, through August 31, 2027, to support the Hematology Bone Marrow Pathology and Consultation Service. This is an active presolicitation notice of intent to use a sole-source acquisition under FAR Part 13, and interested parties must submit capability information by the stated closing date; it is not a grant program or a request for quotations.